Equities

Intelligent Bio Solutions Inc

Intelligent Bio Solutions Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.88
  • Today's Change0.085 / 4.74%
  • Shares traded203.19k
  • 1 Year change-87.16%
  • Beta4.6809
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy1
Outperform0
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The one analyst offering a 12 month price target expects Intelligent Bio Solutions Inc share price to rise to 12.00 in the next year from the last price of 1.88.
High538.3%12.00
Med538.3%12.00
Low538.3%12.00

Earnings history & estimates in USD

On Sep 18, 2024, Intelligent Bio Solutions Inc reported 4th quarter 2024 losses of -1.34 per share.
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate+41.54%
Intelligent Bio Solutions Inc reported annual 2024 losses of -6.38 per share on Sep 18, 2024.
Average growth rate+51.08%
More ▼

Revenue history & estimates in USD

Intelligent Bio Solutions Inc had 4th quarter 2024 revenues of 728.00k. This missed the 1.43m estimate of the one analyst following the company. This was 134.08% above the prior year's 4th quarter results.
Average growth rate+17.97%
Intelligent Bio Solutions Inc had revenues for the full year 2024 of 3.11m. This was 147.77% above the prior year's results.
Average growth rate+167.59%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.